| CAT No: | CL-DXPZ-06 |
| CAS No: | 1781244-56-1 |
| Mol.F: | C23H16F3N5OS |
| Mol.Wt.: | 467.5 |
| Rel. Cas No: | |
| Chemical Name: | 7-(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)-7H-benzo[4,5]imidazo[2,1-b]benzo[4,5]imidazo[2,1-d][1,3,5]thiadiazine |
| SMILES: | Cc1c(OCC(F)(F)F)ccnc1C2Sc3nc4ccccc4n3c5nc6ccccc6n25 |
| Inventory Status: | Custom synthesis |
This impurity is related to Dexlansoprazole degradation impurity is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Dexlansoprazole degradation impurity is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:7-(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)-7H-benzo[4,5]imidazo[2,1-b]benzo[4,5]imidazo[2,1-d][1,3,5]thiadiazineCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Dexlansoprazole Molecular Formula: C23H16F3N5OS
Molecular Weight: 467.5
Storage: Store in a cool, dry place.
| Product Name: | Dexlansoprazole degradation impurity |
| CAS No: | 1781244-56-1 |
| Mol.F.: | C23H16F3N5OS |
| Mol.Wt.: | 467.5 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: